Please Wait
Applying Filters...
menu
    • menu
    Evonik

    Virtual Booth

    Contact Supplier

    Sharp is a global leader in pharmaceutical packaging and clinical trial supply services.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-04-21

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-04-14

    Virtual Booth

    Contact Supplier

    Menu

    Ceftobiprole

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Sales growth for Cresemba & Zevtera trigger payments to Basilea
    Sales growth for Cresemba & Zevtera trigger payments to Basilea

    28 Jan 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/01/28/3016062/0/en/Strong-sales-growth-for-Cresemba-and-Zevtera-trigger-further-milestone-payments-to-Basilea.html

    GLOBENEWSWIRE
    28 Jan 2025
    Share Share
    Innoviva Signs Exclusive Deal to Acquire Zevtera® U.S. Rights
    Innoviva Signs Exclusive Deal to Acquire Zevtera® U.S. Rights

    16 Dec 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241216588264/en

    BUSINESSWIRE
    16 Dec 2024
    Share Share
    Basilea Presents New Ceftobiprole Data At ESCMID Global 2024
    Basilea Presents New Ceftobiprole Data At ESCMID Global 2024

    03 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/03/2874833/0/en/Basilea-reports-presentation-of-new-data-for-ceftobiprole-Zevtera-at-ESCMID-Global-2024.html

    GLOBENEWSWIRE
    03 May 2024
    Share Share
    Basilea reports new data for Zevtera presented at US IDWeek Congress 2023
    Basilea reports new data for Zevtera presented at US IDWeek Congress 2023

    17 Oct 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/10/17/2761159/0/en/Basilea-reports-new-data-for-ceftobiprole-Zevtera-presented-at-US-IDWeek-Congress-2023.html

    GLOBENEWSWIRE
    17 Oct 2023
    Share Share
    Basilea announces publication of phase 3 data on ceftobiprole
    Basilea announces publication of phase 3 data on ceftobiprole

    28 Sep 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/09/28/2750877/0/en/Basilea-announces-New-England-Journal-of-Medicine-publication-of-phase-3-data-on-ceftobiprole-for-the-treatment-of-Staphylococcus-aureus-bacteremia.html

    GLOBENEWSWIRE
    28 Sep 2023
    Share Share
    Basilea announces submission of a NDA to the US FDA for antibiotic ceftobiprole
    Basilea announces submission of a NDA to the US FDA for antibiotic ceftobiprole

    04 Aug 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/08/04/2718726/0/en/Basilea-announces-submission-of-a-New-Drug-Application-to-the-US-Food-and-Drug-Administration-for-its-antibiotic-ceftobiprole.html

    GLOBENEWSWIRE
    04 Aug 2023
    Share Share